Sio Capital Management, LLC Ayala Pharmaceuticals, Inc. Transaction History

Sio Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.99 - $4.15 $59,617 - $249,913	-60,220 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.5 - $9.11 $69,104 - $179,867	-19,744 Reduced 24.69%	60,220 $240,000
Q4 2021 Feb 14, 2022	SELL	$8.32 - $12.45 $1.99 Million - $2.97 Million	-238,635 Reduced 74.9%	79,964 $680,000
Q3 2021 Nov 15, 2021	SELL	$8.13 - $14.09 $1.82 Million - $3.16 Million	-224,378 Reduced 41.32%	318,599 $3.61 Million
Q2 2021 Aug 16, 2021	BUY	$9.2 - $11.3 $487,498 - $598,775	52,989 Added 10.81%	542,977 $5.53 Million

Q1 2021 May 14, 2021	BUY	$10.72 - $22.0 $3.57 Million - $7.33 Million	333,333 Added 212.78%	489,988 $5.35 Million
Q4 2020 Feb 16, 2021	SELL	$9.67 - $13.5 $32,017 - $44,698	-3,311 Reduced 2.07%	156,655 $1.72 Million
Q3 2020 Nov 16, 2020	BUY	$8.8 - $14.55 $399,696 - $660,861	45,420 Added 39.65%	159,966 $1.84 Million
Q2 2020 Aug 14, 2020	BUY	$10.0 - $15.92 $1.15 Million - $1.82 Million	114,546 New	114,546 $1.16 Million

Ticker AYLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,833,300
Description
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.